China Medical Technologies Inc.

Mr. Xiaodong Wu, our founder, currently serves as our chairman of the board of directors and chief executive officer. Mr. Wu has served on our board of directors since July 2004 and as the chairman of our board of directors since February 2005. Mr. Wu is also a director and the chief executive officer of YDME Beijing, positions in which he has served since the inception of YDME Beijing in July 1999. Mr. Wu serves on the board of directors of, Beijing Chengxuan, an investment holding company, Beijing Weixiao, a medical technology company, Beijing Jia Chen Hong Biological Technologies Co., Ltd., a medical technology company, and Beijing Wan De Jin Da Industry and Trade Co., Ltd., a property management company. Mr. Wu worked in the foreign investment department of the Jiangxi provincial government from 1990 to 1996. From 1980 to 1989, he worked in the Jiangxi Municipal Science and Technology Commission and accumulated extensive experience in assessing and managing hi-tech projects. Mr. Wu is an advisor to Beijing Medical University for technology development projects. He received his bachelor’s degree in Physics from Jiangxi University.

Dr. Zhong Chen joined our company in March 2007 as a chief scientist and was appointed Chief Technology Officer in November 2007. Dr. Chen was the Medical Director of the cytogenetics program at the Associated Regional and University Pathologists (ARUP) Laboratories in Utah and a professor of Pediatrics and Pathology at the University of Utah. Before that, he served as the Director of cytogenetics laboratories at two leading biotechnology companies in the United States, namely Genetrix Inc. and Genzyme Genetics. He currently serves as the Associate Editor of the medical journal Cancer Genetics and Cytogenetics. Dr. Chen received his MD in Hematology and Genetics from Tongji Medical University in the PRC and completed his postdoctoral research work at the Southwest Biomedical Research Institute in conjunction with the University of Arizona. He is a certified clinical cytogeneticist of the American Board of Medical Genetics (ABMG).

Mr. Feng (Charles) Zhu joined our company as vice president for business development and investor relations in January 2005. Prior to joining us, Mr. Zhu worked as the business development manager for GE Healthcare in the PRC from February 2002 to December 2004, responsible for merger and acquisition projects. From May 2000 to February 2002, Mr. Zhu also worked as a business analyst for a Siemens joint venture in the PRC, advising clients on fund raising projects. Mr. Zhu received his bachelor’s degree in English from Foreign Affairs College in the PRC and his master’s degree in business administration from Texas Christian University.

Dr. Guoming Qi has served as a member of our board of directors since November 2007. Prior to that, he served as the Director of the Department of Medical Science, Technology and Education of the Ministry of Health in the PRC from 1997 to 2006. He also served as the Deputy Director of the Chinese Center for Disease Control and Prevention from 1992 to 1997. Dr. Qi is currently the Vice President of the Chinese Medical Association, the largest and longest established medical association in the PRC, with over 400,000 members. Additionally, he holds a number of senior positions in various healthcare organizations in the PRC. Dr. Qi graduated from Peking Medical University and obtained his master's degree from the Chinese Academy of Medical Sciences.

Mr. Iain Ferguson Bruce has served as a member of our board of directors since February 2005. Mr. Bruce is a member of the audit, compensation and nomination committees. Mr. Bruce joined KPMG in Hong Kong in 1964 and was promoted to a partner in 1971. He was the Senior Partner of KPMG from 1991 until his retirement in 1996 and concurrently served as Chairman of KPMG Asia Pacific from 1993 to 1997. Mr. Bruce has been a member of the Institute of Chartered Accountants of Scotland since 1964, and is also a fellow of the Hong Kong Institute of Certified Public Accountants, a member of the Hong Kong Securities Institute and a fellow of The Hong Kong Institute of Directors. Mr. Bruce is currently an independent non-executive director of Paul Y Engineering Group Limited, a construction and engineering company, Vitasoy International Holdings Ltd., a beverage manufacturing company, Wing On Company International Ltd., a department store and property investment company, and Tencent Holdings Limited, a provider of Internet services and mobile value-added services. All of these companies are listed companies on the Hong Kong Stock Exchange. Mr. Bruce is also a non-executive director of Noble Group Limited, a commodity trading company that is listed on the Singapore Stock Exchange.

Mr. Iain Ferguson Bruce is an independent member of our board of directors and the chairperson of the audit committee and compensation committee of the board. Mr. Bruce joined KPMG in Hong Kong in 1964 and was elected to its partnership in 1971. He was the senior partner of KPMG from 1991 until his retirement in 1996 and also concurrently served as chairman of KPMG Asia Pacific from 1993 to 1997. Since 1964, Mr. Bruce has been a member of the Chartered Accountants of Scotland and is a fellow of the Hong Kong Institute of Certified Public Accountants with over 40 years' experience in the accounting profession. Mr. Bruce is currently an independent non-executive director of China Medical Technologies, Inc., a NASDAQ-listed, China-based medical device company, Paul Y Engineering Group Limited, a construction and engineering company, Vitasoy International Holdings Ltd., a beverage manufacturing company, Wing On Company International Ltd., a department store operating and real property investment company, and Tencent Holdings Limited, a provider of Internet services and mobile value-added services. All of these companies are listed companies on the Hong Kong Stock Exchange. In addition, Mr. Bruce also serves as a non-executive director of Noble Group Limited, a commodity trading company that is listed on the Singapore Stock Exchange.

Dr. Yuedong Li has served as a member of our board of directors since October 2007. Dr. Li is a member of the audit and nomination committees. Dr. Li joined Peking University People’s Hospital in 1975 as a surgeon and was promoted to Director of General Affairs in 1983. He served as the Vice President of Peking University People’s Hospital from 1987 to 1997. He currently serves as the Chief Secretary of the China Hospital Association and the Deputy Director of the Center for Organ Transplants at Peking University. Dr. Li also holds various positions in a number of medical associations and serves as an editor for a number of medical journals. He has over 30 years of experience in the medical profession and in clinical research and management of a number of healthcare organizations in the PRC. Dr. Li graduated from the Medical School of Peking Medical University.